中华医学会肺癌临床诊疗指南(2019版)

被引:692
作者
ChineseMedicalAssociation
OncologySocietyofChineseMedicalAssociation
ChineseMedicalAssociationPublishingHouse
机构
[1] 中华医学会
[2] 中华医学会肿瘤学分会
[3] 中华医学会杂志社
关键词
肺肿瘤; 诊断; 治疗; 指南;
D O I
暂无
中图分类号
R734 [呼吸系肿瘤];
学科分类号
100117 [系统生物医学];
摘要
制定符合中国国情、多学科共同参与的肺癌临床诊疗指南,对规范防治措施、提高中国肺癌诊治水平起到重要的作用。为进一步提高我国肺癌的诊疗水平、改善患者的预后、给各级临床医师提供专业的循证医学意见,中华医学会组织呼吸内科、肿瘤内科、胸外科、放疗科、影像科和病理科专家,整合近年来肺癌病理、基因检测、免疫分子标志物检测和治疗手段等方面的新进展,并同时考虑中国的实际国情和诊治的可及性,结合国际指南和中国国情,制定了中国肺癌临床诊疗指南,旨在为肺癌专业的各级临床医师提供循证、指导性意见。指南的内容覆盖肺癌的筛查、诊断、病理、治疗和随访情况等。
引用
收藏
相关论文
共 190 条
[1]
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study [J].
Zhou, Caicun ;
Kim, Sang-We ;
Reungwetwattana, Thanyanan ;
Zhou, Jianying ;
Zhang, Yiping ;
He, Jianxing ;
Yang, Jin-Ji ;
Cheng, Ying ;
Lee, Se-Hoon ;
Bu, Lilian ;
Xu, Tingting ;
Yang, Li ;
Wang, Chao ;
Liu, Ting ;
Morcos, Peter N. ;
Lu, You ;
Zhang, Li .
LANCET RESPIRATORY MEDICINE, 2019, 7 (05) :437-446
[2]
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial [J].
Mok, Tony S. K. ;
Wu, Yi-Long ;
Kudaba, Iveta ;
Kowalski, Dariusz M. ;
Cho, Byoung Chul ;
Turna, Hande Z. ;
Castro, Gilberto, Jr. ;
Srimuninnimit, Vichien ;
Laktionov, Konstantin K. ;
Bondarenko, Igor ;
Kubota, Kaoru ;
Lubiniecki, Gregory M. ;
Zhang, Jin ;
Kush, Debra ;
Lopes, Gilberto .
LANCET, 2019, 393 (10183) :1819-1830
[3]
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial [J].
Wu, Yi-Long ;
Lu, Shun ;
Cheng, Ying ;
Zhou, Caicun ;
Wang, Jie ;
Mok, Tony ;
Zhang, Li ;
Tu, Hai-Yan ;
Wu, Lin ;
Feng, Jifeng ;
Zhang, Yiping ;
Luft, Alexander Valerievich ;
Zhou, Jianying ;
Ma, Zhiyong ;
Lu, You ;
Hu, Chengping ;
Shi, Yuankai ;
Baudelet, Christine ;
Cai, Junliang ;
Chang, Jianhua .
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) :867-875
[4]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Siegel, Rebecca L. ;
Torre, Lindsey A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :394-424
[5]
Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032.[J].Neal Ready;Anna F. Farago;Filippo de Braud;Akin Atmaca;Matthew D. Hellmann;Jeffrey G. Schneider;David R. Spigel;Victor Moreno;Ian Chau;Christine L. Hann;Joseph Paul Eder;Nicola L. Steele;Anne Pieters;Justin Fairchild;Scott J. Antonia.Journal of Thoracic Oncology.2018, 2
[6]
Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations [J].
Mok, Tony S. ;
Cheng, Ying ;
Zhou, Xiangdong ;
Lee, Ki Hyeong ;
Nakagawa, Kazuhiko ;
Niho, Seiji ;
Lee, Min ;
Linke, Rolf ;
Rosell, Rafael ;
Corral, Jesus ;
Migliorino, Maria Rita ;
Pluzanski, Adam ;
Sbar, Eric I. ;
Wang, Tao ;
White, Jane Liang ;
Wu, Yi-Long .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (22) :2244-+
[7]
Consolidative Local Ablative Therapy Improves the Survival of Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Activating Mutation Treated With First-Line EGFR-TKIs [J].
Xu, Qinghua ;
Zhou, Fei ;
Liu, Hui ;
Jiang, Tao ;
Li, Xuefei ;
Xu, Yaping ;
Zhou, Caicun .
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (09) :1383-1392
[8]
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study [J].
Novello, S. ;
Mazieres, J. ;
Oh, I-J. ;
de Castro, J. ;
Migliorino, M. R. ;
Helland, A. ;
Dziadziuszko, R. ;
Griesinger, F. ;
Kotb, A. ;
Zeaiter, A. ;
Cardona, A. ;
Balas, B. ;
Johannsdottir, H. K. ;
Das-Gupta, A. ;
Wolf, J. .
ANNALS OF ONCOLOGY, 2018, 29 (06) :1409-1416
[9]
Community-based lung cancer screening with low-dose CT in China: Results of the baseline screening.[J].Wenjia Yang;Fangfei Qian;Jiajun Teng;Huimin Wang;Christian Manegold;Lothar R. Pilz;Weiland Voigt;Yanwei Zhang;Jianding Ye;Qunhui Chen;Baohui Han.Lung Cancer.2018,
[10]
Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma [J].
Qian, Fangfei ;
Yang, Wenjia ;
Wang, Rui ;
Xu, Jianlin ;
Wang, Shuyuan ;
Zhang, Yanwei ;
Jin, Bo ;
Yu, Keke ;
Han, Baohui .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (03) :1227-+